Skip to main content

Lynx1 Capital Management LP

Position in CCCC — C4 Therapeutics, Inc.

CIK 1910456 DORADO, PR

Position in CCCC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$34,215,646
+$15,808,534 QoQ
Shares Held
7,326,691
+4.7% QoQ
Ownership
5.96%
of shares outstanding
% of Portfolio
3.95%
of 13F equity value
Holder Rank
#4
of 147 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CCCC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Lynx1 Capital Management LP holds $865,408,538 across 26 Biotechnology names. CCCC ranks #5 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 CCCC
C4 Therapeutics, Inc.
This page
7,326,691 $34,215,646

All Filings in CCCC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,215,646 7,326,691
2026-06-30 $72,028,636 15,423,691
2026-03-31 $18,407,112 6,998,902
2025-12-31 $13,557,434 7,098,133
2025-09-30 $15,757,855 7,098,133
2025-06-30 $10,150,330 7,098,133
2025-03-31 $11,357,012 7,098,133
2024-12-31 $24,669,878 6,852,744
2024-09-30 $39,219,003 6,880,527
2024-06-30 $31,788,034 6,880,527
2024-03-31 $29,695,188 3,634,662
2023-12-31 $17,709,337 3,134,396
2023-09-30 $1,895,767 1,019,230